vs
CIVITAS RESOURCES, INC.（CIVI）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
CIVITAS RESOURCES, INC.的季度营收约是Royalty Pharma plc的1.9倍（$1.2B vs $622.0M），Royalty Pharma plc同比增速更快（4.8% vs -8.2%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 1.8%）
Civitas Resources是一家总部位于美国的可持续能源企业，主要从事石油、天然气及天然气凝液的勘探、开发与生产业务，核心运营区域位于科罗拉多州丹佛-朱尔斯堡盆地，专注于低排放的负责任能源开发，服务北美能源市场需求。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CIVI vs RPRX — 直观对比
营收规模更大
CIVI
是对方的1.9倍
$622.0M
营收增速更快
RPRX
高出13.0%
-8.2%
两年增速更快
RPRX
近两年复合增速
1.8%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | — | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 20.0% | 62.4% |
| 净利率 | — | 34.4% |
| 营收同比 | -8.2% | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | $1.99 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CIVIRPRX
| Q4 25 | — | $622.0M | ||
| Q3 25 | $1.2B | $609.3M | ||
| Q2 25 | $1.1B | $578.7M | ||
| Q1 25 | $1.2B | $568.2M | ||
| Q4 24 | $1.3B | $593.6M | ||
| Q3 24 | $1.3B | $564.7M | ||
| Q2 24 | $1.3B | $537.3M | ||
| Q1 24 | $1.3B | $568.0M |
净利润CIVIRPRX
| Q4 25 | — | $214.2M | ||
| Q3 25 | — | $288.2M | ||
| Q2 25 | — | $30.2M | ||
| Q1 25 | — | $238.3M | ||
| Q4 24 | — | $208.2M | ||
| Q3 24 | — | $544.0M | ||
| Q2 24 | — | $102.0M | ||
| Q1 24 | — | $4.8M |
营业利润率CIVIRPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | 20.0% | 70.1% | ||
| Q2 25 | 15.3% | 36.3% | ||
| Q1 25 | 20.7% | 94.0% | ||
| Q4 24 | 15.4% | 60.9% | ||
| Q3 24 | 30.6% | — | ||
| Q2 24 | 21.6% | 50.2% | ||
| Q1 24 | 15.9% | -13.0% |
净利率CIVIRPRX
| Q4 25 | — | 34.4% | ||
| Q3 25 | — | 47.3% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 35.1% | ||
| Q3 24 | — | 96.3% | ||
| Q2 24 | — | 19.0% | ||
| Q1 24 | — | 0.8% |
每股收益（稀释后）CIVIRPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | $1.99 | $0.67 | ||
| Q2 25 | $1.34 | $0.07 | ||
| Q1 25 | $1.99 | $0.55 | ||
| Q4 24 | $1.56 | $0.46 | ||
| Q3 24 | $3.01 | $1.21 | ||
| Q2 24 | $2.15 | $0.23 | ||
| Q1 24 | $1.74 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $56.0M | $618.7M |
| 总债务越低越好 | $5.1B | $9.0B |
| 股东权益账面价值 | $6.7B | $9.7B |
| 总资产 | $15.1B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.77× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CIVIRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | $56.0M | $938.9M | ||
| Q2 25 | $69.0M | $631.9M | ||
| Q1 25 | $20.0M | $1.1B | ||
| Q4 24 | $76.0M | $929.0M | ||
| Q3 24 | $47.1M | $950.1M | ||
| Q2 24 | $91.9M | $1.8B | ||
| Q1 24 | $52.1M | $843.0M |
总债务CIVIRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | $5.1B | $8.9B | ||
| Q2 25 | $5.4B | $8.0B | ||
| Q1 25 | $5.1B | $7.6B | ||
| Q4 24 | $4.5B | $7.6B | ||
| Q3 24 | $4.8B | $7.6B | ||
| Q2 24 | $4.9B | $7.6B | ||
| Q1 24 | $4.4B | $6.1B |
股东权益CIVIRPRX
| Q4 25 | — | $9.7B | ||
| Q3 25 | $6.7B | $9.6B | ||
| Q2 25 | $6.8B | $9.5B | ||
| Q1 25 | $6.7B | $9.8B | ||
| Q4 24 | $6.6B | $10.3B | ||
| Q3 24 | $6.7B | $10.3B | ||
| Q2 24 | $6.6B | $9.8B | ||
| Q1 24 | $6.6B | $9.9B |
总资产CIVIRPRX
| Q4 25 | — | $19.6B | ||
| Q3 25 | $15.1B | $19.3B | ||
| Q2 25 | $15.4B | $18.3B | ||
| Q1 25 | $15.3B | $17.6B | ||
| Q4 24 | $14.9B | $18.2B | ||
| Q3 24 | $15.0B | $18.0B | ||
| Q2 24 | $15.0B | $17.7B | ||
| Q1 24 | $15.1B | $16.1B |
负债/权益比CIVIRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | 0.77× | 0.93× | ||
| Q2 25 | 0.79× | 0.84× | ||
| Q1 25 | 0.76× | 0.78× | ||
| Q4 24 | 0.68× | 0.74× | ||
| Q3 24 | 0.73× | 0.74× | ||
| Q2 24 | 0.74× | 0.78× | ||
| Q1 24 | 0.67× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $860.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CIVIRPRX
| Q4 25 | — | $827.1M | ||
| Q3 25 | $860.0M | $702.6M | ||
| Q2 25 | $298.0M | $364.0M | ||
| Q1 25 | $719.0M | $596.1M | ||
| Q4 24 | $858.2M | $742.5M | ||
| Q3 24 | $835.0M | $703.6M | ||
| Q2 24 | $359.0M | $658.2M | ||
| Q1 24 | $813.0M | $664.6M |
现金转化率CIVIRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CIVI
| Crude Oil Natural Gas And Natural Gas Liquids | $1.2B | 99% |
| Oil And Gas Operation And Maintenance | $8.0M | 1% |
| Natural Gas Reserves | $2.0M | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
